Actionnariat et activité des initiés pour EyePoint Pharmaceuticals, Inc. (EYPT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.45 |
| Capitalisation | $289M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-20 | Elston George | J-Other | 5,000 | |
| 2026-08-20 | Elston George | G-Gift | 64,953 | |
| 2026-08-20 | Elston George | G-Gift | 64,953 | |
| 2026-08-20 | Elston George | J-Other | 5,000 | |
| 2026-08-18 | Zaderej Karen L. | P-Purchase | 10,600 | $52K |
| 2026-07-10 | Duker Jay S. | M-Exempt | 16,667 | |
| 2026-07-10 | Duker Jay S. | F-InKind | 8,059 | $119K |
| 2026-07-10 | Duker Jay S. | M-Exempt | 16,667 | |
| 2026-06-30 | Ribeiro Ramiro | M-Exempt | 2,437 | $20K |
| 2026-06-30 | Ribeiro Ramiro | M-Exempt | 2,438 | $20K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $16.9M | $16.9M | $45.3M | $22.2M | $44.9M | $178.6M | $95.6M | $281.3M | $99.7M | $101.8M |
| Placements à Court Terme | $5.8M | 0 | 0 | 0 | 0 | $33.0M | $48.9M | $49.8M | $271.2M | $204.3M |
| Créances | $251000 | $353000 | $627000 | $11.4M | $9.5M | $18.4M | $15.5M | $805000 | $607000 | $651000 |
| Stocks | 0 | -$251000 | $279000 | $2.1M | $5.3M | $3.6M | $2.9M | $3.9M | $2.3M | $1.8M |
| Actifs Courants | $17.7M | $17.7M | $47.6M | $41.7M | $63.1M | $237.7M | $172.8M | $344.8M | $383.3M | $328.7M |
| Immobilisations Corporelles | $290000 | $313000 | $253000 | $3.4M | $3.2M | $2.7M | $7.4M | $10.2M | $29.2M | $20.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $1.1M | $364000 | $31.4M | $27.7M | $25.2M | $22.7M | 0 | 0 | 0 | 0 |
| Actifs Totaux | $18.7M | $18.7M | $78.2M | $73.0M | $91.7M | $263.4M | $180.4M | $355.2M | $418.5M | $364.0M |
| Dettes Fournisseurs | $1.0M | $2.9M | $2.6M | $4.2M | $4.8M | $7.4M | $5.9M | $6.5M | $11.7M | $10.5M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | $10.5M | 0 | 0 | 0 |
| Passifs Courants | $5.3M | $5.3M | $21.5M | $11.5M | $14.9M | $23.7M | $34.5M | $63.3M | $49.0M | $37.0M |
| Dette à Long Terme | 0 | $17.3M | $17.6M | $47.2M | $38.0M | $36.6M | $29.3M | 0 | 0 | 0 |
| Passifs Totaux | $5.3M | $5.3M | $60.0M | $64.6M | $73.2M | $79.0M | $84.0M | $88.9M | $82.0M | $57.9M |
| Réserves | -$310.8M | -$364.0M | -$408.5M | -$465.3M | -$510.7M | -$569.1M | -$671.4M | -$742.1M | -$873.0M | -$1.10B |
| Capitaux Propres | $13.3M | $11.7M | $37.6M | $8.3M | $18.5M | $184.4M | $96.4M | $266.3M | $336.5M | $306.1M |
| Dette Totale | 0 | $17.3M | $17.3M | $50.6M | $41.0M | $39.2M | $46.3M | $4.9M | $21.9M | $22.8M |
| Dette Nette | -$16.9M | $411000 | -$28.0M | $28.4M | -$3.9M | -$172.4M | -$98.2M | -$326.1M | -$349.1M | -$283.3M |
| Fonds de Roulement | $12.4M | $12.4M | $26.1M | $30.2M | $48.2M | $214.1M | $138.3M | $281.5M | $334.3M | $291.6M |
Santé financière
| Dette / Capitaux propres | 0.13 |
| Ratio de liquidité | 4.50 |
Rentabilité
| Rentabilité des capitaux propres | -75.78% |
| Rentabilité du capital investi | -73.99% |
| Rentabilité des actifs | -63.73% |
| Marge brute | 41.77% |
| Marge opérationnelle | -11365.22% |
| Marge nette | -10994.73% |
Entreprises liées: BCAX · KOD · KURA · NRIX · PRME · PROK · RZLT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de EYPT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions